撤回：肯尼亚HIV阳性和HIV阴性女性中阴道用青蒿琥酯阴道栓治疗宫颈上皮内瘤变2/3：一项试点试验的研究方案。
WITHDRAWN: Intravaginal artesunate pessaries for treatment of cervical intraepithelial neoplasia 2/3 among HIV-positive and HIV-negative women in Kenya: Study protocol for a pilot trial.
作者信息
Mungo Chemtai, Sorgi Katherine, Hoch Caroline, Tang Jennifer, Rahangdale Lisa, Omoto Jackton
出版信息
medRxiv. 2024 Dec 18:2024.06.27.24309586. doi: 10.1101/2024.06.27.24309586.
Abstract
The authors have withdrawn this manuscript because the article was posted prior to consultation from all relevant collaborators. If you have any questions, please contact the corresponding author.
摘要
作者已撤回此稿件，因为该文章在未征得所有相关合作者同意的情况下就已发布。如果您有任何疑问，请联系通讯作者。
相似文献
1
WITHDRAWN: Intravaginal artesunate pessaries for treatment of cervical intraepithelial neoplasia 2/3 among HIV-positive and HIV-negative women in Kenya: Study protocol for a pilot trial.
medRxiv. 2024 Dec 18:2024.06.27.24309586. doi: 10.1101/2024.06.27.24309586.
2
Feasibility of adjuvant self-administered intravaginal 5-fluorouracil cream following primary treatment of cervical intraepithelial neoplasia grade 2 or 3 among women living with HIV in Kenya: study protocol for a pilot trial.
medRxiv. 2023 Dec 14:2023.12.13.23299916. doi: 10.1101/2023.12.13.23299916.
3
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.
PLoS One. 2025 Apr 9;20(4):e0316334. doi: 10.1371/journal.pone.0316334. eCollection 2025.
4
Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
Int J Gynaecol Obstet. 2025 May;169(2):781-787. doi: 10.1002/ijgo.16093. Epub 2024 Dec 26.
5
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.
medRxiv. 2025 Feb 19:2024.07.08.24309596. doi: 10.1101/2024.07.08.24309596.
6
Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
medRxiv. 2024 Jun 7:2024.06.06.24308548. doi: 10.1101/2024.06.06.24308548.
7
A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.
Am J Obstet Gynecol. 2017 Aug;217(2):183.e1-183.e11. doi: 10.1016/j.ajog.2017.03.022. Epub 2017 Mar 31.
8
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
Gynecol Oncol. 2020 Apr;157(1):188-194. doi: 10.1016/j.ygyno.2019.12.035. Epub 2020 Jan 28.
9
WITHDRAWN: Structural Enzymology, Phylogenetics, Differentiation, and Symbolic Reflexivity at the Dawn of Biology.
bioRxiv. 2025 Jan 14:2024.12.17.628912. doi: 10.1101/2024.12.17.628912.
10
[WITHDRAWN] Spatial enrichment of the type 1 interferon signature in the brain of a neuropsychiatric lupus murine model.
bioRxiv. 2023 Sep 6:2023.04.21.537814. doi: 10.1101/2023.04.21.537814.
本文引用的文献
1
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
N Engl J Med. 2022 Jun 16;386(24):2273-2282. doi: 10.1056/NEJMoa2201048.
2
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
Front Pharmacol. 2021 Dec 31;12:828856. doi: 10.3389/fphar.2021.828856. eCollection 2021.
3
Cervical cancer prevention and control in women living with human immunodeficiency virus.
CA Cancer J Clin. 2021 Nov;71(6):505-526. doi: 10.3322/caac.21696. Epub 2021 Sep 9.
4
Malaria and Cancer: a critical review on the established associations and new perspectives.
Infect Agent Cancer. 2021 May 13;16(1):33. doi: 10.1186/s13027-021-00370-7.
5
Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Obstet Gynecol. 2021 Jun 1;137(6):1043-1053. doi: 10.1097/AOG.0000000000004384.
6
Neonatal Survival in Sub-Sahara: A Review of Kenya and South Africa.
J Multidiscip Healthc. 2020 Jul 29;13:709-716. doi: 10.2147/JMDH.S260058. eCollection 2020.
7
Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2-3: A narrative review.
Gynecol Oncol Rep. 2020 Jul 2;33:100608. doi: 10.1016/j.gore.2020.100608. eCollection 2020 Aug.
8
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
Gynecol Oncol. 2020 Apr;157(1):188-194. doi: 10.1016/j.ygyno.2019.12.035. Epub 2020 Jan 28.
9
Radical hysterectomy for operable early cervical cancer in HIV-positive and HIV-negative women in western Kenya.
Int J Gynaecol Obstet. 2020 Mar;148(3):403-404. doi: 10.1002/ijgo.13004. Epub 2019 Nov 5.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
Zotero 插件